It’s one of Europe’s major industrial players, but Bayer continues to struggle. It’s takeover of controversial seed- and chemicals-giant Monsanto in 2018 saddled it with billions in legal fees and payments from the pesticide known as "Roundup." New court judgments added to its woes this year – Bayer stock is down 30 percent from the beginning of 2023. Investors are growing restless.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2024
Categories |